Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02368691
Title Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors GTx
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Holy Cross Hospital Fort Lauderdale Florida 33308 United States Details
Lakeland Regional Health Care/Cancer Center Lakeland Florida 33805 United States Details
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
St. Vincent Frontier Cancer Center Billings Montana 59102 United States Details
The West Clinic, PC Memphis Tennessee 38120 United States Details
US Oncology / Texas Oncology, P.A. Houston Texas 77024 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field